{"eventGroups":[{"deathsNumAffected":0,"deathsNumAtRisk":151,"description":"Acupuncture will start on Day 0 and continue once daily to Day 15, as long as the patient is inpatient or comes to the clinic for post-transplantation follow-up. to prevent severe pain. If acupuncture does not prevent severe pain, the participant will receive opioid medication as backup pain relief.\n\nAcupuncture: Acupuncture treatments will be scheduled to cover the period of high symptom burden. Acupuncture will start on Day 0 and continue once daily to Day 15, as long as the patient is inpatient or comes to the clinic for post-transplantation follow-up. Electrical stimulation (e-acupuncture) may be applied to the ST36 and SP6 points when appropriate as per standard acupuncture practice.\n\nopioid: All study patients will receive the usual HSCT care and pain management regimens (usually opioids) as per standard practice at the study institution.\n\nAssessments: Participants will be asked to complete patient reported outcomes assessments online using REDCap or, If they prefer, via pencil and paper or over the phone. Assessments at baseline (within 4 weeks before HiChemo) and on or about days 7, 15, 30, and 90 after the first dose of HiChemo.","id":"EG000","otherNumAffected":39,"otherNumAtRisk":151,"seriousNumAffected":0,"seriousNumAtRisk":151,"title":"Acupuncture Plus Usual Care"},{"deathsNumAffected":0,"deathsNumAtRisk":147,"description":"Will receive only the usual pain management approach, which includes opioid medication when needed for severe pain, according to the routine guidelines for their care.\n\nopioid: All study patients will receive the usual HSCT care and pain management regimens (usually opioids) as per standard practice at the study institution.\n\nAssessments: Participants will be asked to complete patient reported outcomes assessments online using REDCap or, If they prefer, via pencil and paper or over the phone. Assessments at baseline (within 4 weeks before HiChemo) and on or about days 7, 15, 30, and 90 after the first dose of HiChemo.","id":"EG001","otherNumAffected":0,"otherNumAtRisk":147,"seriousNumAffected":0,"seriousNumAtRisk":147,"title":"Usual Care"}],"frequencyThreshold":"0","otherEvents":[{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Injury, poisoning and procedural complications","stats":[{"groupId":"EG000","numAffected":26,"numAtRisk":151},{"groupId":"EG001","numAffected":0,"numAtRisk":147}],"term":"Bruising"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"General disorders","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":151},{"groupId":"EG001","numAffected":0,"numAtRisk":147}],"term":"Burning sensation"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Skin and subcutaneous tissue disorders","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":151},{"groupId":"EG001","numAffected":0,"numAtRisk":147}],"term":"Skin discoloration"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Musculoskeletal and connective tissue disorders","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":151},{"groupId":"EG001","numAffected":0,"numAtRisk":147}],"term":"Foot cramping"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Respiratory, thoracic and mediastinal disorders","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":151},{"groupId":"EG001","numAffected":0,"numAtRisk":147}],"term":"Nose bleed"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"General disorders","stats":[{"groupId":"EG000","numAffected":7,"numAtRisk":151},{"groupId":"EG001","numAffected":0,"numAtRisk":147}],"term":"Pain/Soreness"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"General disorders","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":151},{"groupId":"EG001","numAffected":0,"numAtRisk":147}],"term":"Throbbing sensation"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"General disorders","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":151},{"groupId":"EG001","numAffected":0,"numAtRisk":147}],"term":"Tiredness"}],"timeFrame":"90 days"}